Literature DB >> 15604874

Corneal endothelial abnormalities associated with thalidomide toxicity.

Sathish Srinivasan1, Inma Perez-Gomez, Clare O'Donnell, Mark Batterbury.   

Abstract

PURPOSE: To describe bilateral corneal endothelial abnormalities associated with thalidomide toxicity.
METHODS: Observational case report.
RESULTS: A 30-year-old man, born with bilateral hypoplastic upper limb defects (phocomelia) caused by thalidomide toxicity, presented with bilateral symmetrical corneal endothelial changes resembling guttata without corneal edema. Pachymetry, specular microscopy, and confocal microscopy were performed. Biomicroscopy findings over a 10-year follow-up showed no changes.
CONCLUSIONS: Nonprogressive bilateral corneal endothelial changes resembling cornea guttata should possibly be included in the ocular manifestations of thalidomide toxicity. We postulate that thalidomide may have affected the migration and development of the mesenchymal neural crest cells, which are the developmental precursors of the corneal endothelium and stroma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15604874     DOI: 10.1097/01.ico.0000133998.45262.ca

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

1.  Thalidomide and its analogues: A review of the potential for immunomodulation of fibrosis diseases and opthalmopathy.

Authors:  Ting Liu; Feng Guo; Xiaomin Zhu; Xiangge He; Lin Xie
Journal:  Exp Ther Med       Date:  2017-09-27       Impact factor: 2.447

2.  Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells.

Authors:  K P Tamilarasan; Gopi Krishna Kolluru; Megha Rajaram; M Indhumathy; R Saranya; Suvro Chatterjee
Journal:  BMC Cell Biol       Date:  2006-04-04       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.